INFORMATION FOR
News
Beta blockers are not effective in preventing development of varices—veins in the esophagus that can rupture and bleed—as a consequence of cirrhosis, according to a recent study by Yale School of Medicine researchers in the New England Journal of Medicine.
Three Research Scientists and four Yale School of Medicine faculty of the Yale Cancer Center were celebrated in mid-February 2025 during a celebration in downtown New Haven.
Yale researchers have shown that individuals who carry a mutation in the CDH1 gene have a 30% to 40% risk of developing stomach cancer during their lifetime. Yet many people with the rare inherited condition remain unaware that they have it.
Deborah Proctor, MD, was presented with the 2023 William. J. Pomfret Veteran Community Service Award by the Middlesex County Chamber of Commerce.
Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases), has been named to the Cancer Committee of the College of American Pathologists (CAP), the leading organization of board-certified pathologists that fosters and advocates excellence in the practice of pathology and laboratory medicine worldwide.
According to the lead author of a recent study, the keto diet’s effectiveness derives from its ability to trick the body into burning fat. Vishwa Deep Dixit, DVM, PhD, the Waldemar Von Zedwitz Professor of Comparative Medicine and professor of immunology, evaluated the mechanisms by which the..
Among the many reasons the VA Connecticut Healthcare System in West Haven is regarded as one of the best in the country is its expertise in treating liver disease. This legacy extends back over decades and is the result of many illustrious physicians and researchers building on the work of their..
Growing evidence suggests that certain types of bacteria are capable of causing colorectal cancers, indicating that a sub-set of these cancers could be the result of infectious disease.
Jane Norgren was suffering terribly. A pernicious bacterium, Clostridium difficile, had taken up residence in her colon and refused to leave—no matter what antibiotics she took.
Bacteria that escape the gut microbiome, known as “leaky gut,” may play a role in the development of autoimmune diseases like multiple sclerosis (MS).
“Consider the gut microbiome as the center of the world,” says Li Wen, MD, PhD, FW ’97, associate professor of medicine (endocrinology). At the center of a lined notepad, Wen draws a circle: this is the gut microbiome.
Walter E. Longo, MD, MBA, FACS, FASCRS was honored with the inaugural Rosemarie L. Fisher, M.D., Graduate Medical Education (GME) Leadership Award
The longstanding struggle between humans and an array of microscopic, disease–bearing viruses intent on killing remains a pitched battle. There are many victims and no end in sight.
Dr. Loren Laine, Yale gastroenterologist, has won the American Gastroenterological Association’s (AGA) highest honor, the Julius Friedenwald Medal. He will be presented with the honor at the annual Digestive Disease Week conference on June 25 in Washington, D.C.
Rosemarie L. Fisher, M.
Connecticut Magazine’s 2016 Top Doctors listing includes 60 Yale Medical Group physicians.
How a doctor worked with engineering students to fins a way to transport intestines for transplant.
Colonoscopies are now a routine preventive diagnostic test for millions of Americans each year. While rates are low, complications like perforation, bleeding, and anesthesia-related heart failure can occur. Yale School of Medicine researchers have now developed a quality measure that uses follow-up hospital visits to track the variation in colonoscopy quality among outpatient facilities.
Please join us in welcoming our newest faculty member, Matthew Hubbard, M.D., M.S., to the Yale School of Medicine Department of Surgery. Dr. Hubbard joined the Section of Gastrointestinal, Bariatrics as an Assistant Professor in 2015.
The International Society of Gastrointestinal Oncology (ISGIO) has named Howard Hochster, MD, as president elect. Hochster, Professor of Medical Oncology; Associate Director for Clinical Sciences at Yale Cancer Center; and Director of the Gastrointestinal Cancers Program at Smilow Cancer Hospital at Yale-New Haven, will serve a two-year term as president-elect followed by two years as president.